Pharmaceutical News

RSS

Results from Bionovo's study on BN107 published

Bionovo, Inc. announced today the publication of results from its study on the anti-tumor mechanism of BN107. The results of the study, published in the International Journal of Cancer, describe the potential molecular mechanisms mediating the selective pro-apoptotic (cell death) effect induced by BN107 on estrogen receptor negative (ER-) breast cancer cells.

29 Dec 2009

Department of Health offers statewide H1N1 vaccination; urges all Pennsylvanians to get vaccinated

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 4,003,100 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.

29 Dec 2009

Over 5,000 "Not Recommended" Internet drug outlets

On December 11, 2009, the National Association of Boards of Pharmacy(R) (NABP(R)) reached a bitter-sweet milestone in its ongoing review of Web sites selling prescription medications. NABP now lists more than 5,000 Internet drug outlets as Not Recommended. These sites -- 96% of the total number of sites reviewed -- have been found to be out of compliance with pharmacy laws and practice standards established in the United States to protect the public health.

29 Dec 2009

Managing overwhelming multiple medications, Medco offers free guide for America's seniors

America's seniors are being overwhelmed by the number of prescription drugs they take on a daily basis. According to a new national survey of more than 1,000 people ages 65 and older who use medications, more than half (51 percent) take at least five different prescription drugs regularly and one in four take between 10 and 19 pills each day.

29 Dec 2009

Selected store locations in Massachusetts, Virginia and California to receive H1N1 flu vaccinations

CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Massachusetts, Virginia and Orange County, California beginning Tuesday, December 29.

29 Dec 2009

Tego Biosciences sells intellectual property portfolio to Luna Innovations

Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines

29 Dec 2009

CGEN-671, a new drug target for multiple epithelial tumors discovered by Compugen

Compugen Ltd. announced today the discovery and experimental validation of CGEN-671, a new drug target for multiple epithelial tumors.

28 Dec 2009

CoachRx: An interactive website for CIGNA’s customers

As former Surgeon General C. Everett Koop, M.D. once said, “Drugs don’t work in patients who don’t take them.” That’s why CIGNA is introducing CoachRx, an interactive Web site to help CIGNA Home Delivery Pharmacy customers identify their personal barriers to taking their medications, and then providing ways to help people stay on track with the medications they need.

28 Dec 2009

Sudden worldwide increase in antibiotic-resistant bacterium, a cause for concern

A sudden worldwide increase in an antibiotic-resistant bacterium is cause for concern, according to a review in f1000 Medicine Reports.

28 Dec 2009

Steroids not superior to laser treatments for DME

Researchers led by specialists at the Johns Hopkins Wilmer Eye Institute have found that injecting a corticosteroid, triamcinolone, directly into the eye may slow the progression of proliferative diabetic retinopathy, a complication of diabetes that frequently leads to blindness.

27 Dec 2009

FDA provides guidance on applying for orphan drug designation

As part of its continuing effort to make the agency more transparent and accessible, the FDA has scheduled a series of workshops about orphan drug designation for academics, biotechnology companies, and those unfamiliar with the process. The

24 Dec 2009

CVS/pharmacy and MinuteClinic expand H1N1 vaccine outreach effort

CVS/pharmacy, the nation's leading retail pharmacy, and MinuteClinic, the largest retail health care provider in the U.S., announced today an expanded H1N1 vaccine outreach effort.

24 Dec 2009

Walgreens offers H1N1 vaccinations throughout Indiana

Walgreens, the nation’s largest drugstore chain and industry leader with more than 17,000 certified or licensed immunizers, is now offering H1N1 vaccinations at all of its pharmacies throughout Indiana.

24 Dec 2009

UCB's Cimzia gains market share of Centocor's Simponi

BioTrends Research Group, Inc. announces the release of the final wave of LaunchTrends®: Simponi and Cimzia report. The survey was completed by U.S. Rheumatologists.

24 Dec 2009

New study indicates growing number of people are abusing prescription painkillers

This entire year was marked by an abundance of media coverage and attention surrounding prescription painkillers, largely the result of widespread misuse throughout Hollywood.

24 Dec 2009

Salix Pharmaceuticals sued over alleged kidney damage due to OsmoPrep

Suits were commenced Dec. 23, 2009 in North Carolina for four users who allege kidney damage due to the use of OsmoPrep, a prescription drug used to cleanse the intestines in preparation for a colonoscopy. (Holshouser et al v. Salix Pharmaceuticals, Ltd. and Salix Pharmaceuticals. Inc.)

24 Dec 2009

Smith & Nephew adds PELNAC dermal replacement wound product to its portfolio

Smith & Nephew (LSE: SN) Advanced Wound Management division, announces the agreement to partner with Gunze Limited, Japan and exclusively distribute PELNAC dermal replacement in Japan, South Africa, Australia and New Zealand.

24 Dec 2009

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.

24 Dec 2009

Oxford Outcomes becomes a member of SAFE-BioPharma Association

Oxford Outcomes, an international health outcomes consultancy, has become a member of SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

24 Dec 2009

Drug companies winners of the American prescription drug debate

On Dec. 15, the Obama Administration rejected a plan to allow the wholesale reimportation of cheaper prescriptions drugs from abroad, despite projected intentions to take on the drug industry and secure cheaper prescription for Americans.

24 Dec 2009